Krka is the 40th foreign company listed on the WSE Main Market and the second Slovenian company on the WSE after Nova Kreditna Banka Maribor. It is the fifth new listing on the WSE Main Market this year and the 430th company listed on the market.
The company introduced to trading 32,426 thousand ordinary shares with a total value of over EUR 1,790 million. The company has previously been listed only on the Ljubljana Stock Exchange. The reference price for the first day of trading on the WSE was PLN 202.10 (determined on the basis of yesterday’s closing price on the Ljubljana Stock Exchange and the euro exchange rate quoted by the National Bank of Poland).
“It is with great satisfaction that we welcome the decision of the issuer, previously listed on an exchange which is a subsidiary of the Vienna Stock Exchange, to introduce shares to trading in Warsaw. I wish to thank investment banks engaged in the process for their co-operation,” said WSE CEO Ludwik Sobolewski.
Krka Group has more than 55 years of experience in the pharmaceutical industry. It develops, manufactures, sells and markets medicines and veterinary products. The Group also provides tourist services and operates spas and resorts. The Group is comprised of the company and 25 subsidiaries present in Slovenia and other countries (23 countries in total).
Krka is a leading producer on the local market and has a strong position on the markets of generic pharmaceutical products in South-Eastern Europe. The company’s revenue was EUR 1,075 million in 2011 as compared to EUR 1,010 million in 2010. The company operates a production and distribution business in Slovenia, Poland, Croatia, the Russian Federation and Germany.